Cargando…
Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition
Aim: Our study investigated the association between soluble endoglin and carotid subclinical atherosclerosis. Methods: We used endoglin as an adjunct to atherosclerotic cardiovascular disease (ASCVD) risk, in recognition of carotid clinical atherosclerosis, in order to explore a new model to refine...
Autores principales: | Li, Qiaowei, Lin, Fan, Ke, Douli, Cheng, Qiong, Gui, Yongzhi, Zhou, Yuyan, Wu, Yicheng, Wang, Yinzhou, Zhu, Pengli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192815/ https://www.ncbi.nlm.nih.gov/pubmed/31406054 http://dx.doi.org/10.5551/jat.50898 |
Ejemplares similares
-
Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities
por: Li, Qiaowei, et al.
Publicado: (2020) -
Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017) -
Association of hyperuricemia combined with sarcopenia on ASCVD risk
por: Nie, Guqiao, et al.
Publicado: (2023) -
Contrasting Roles of Different Endoglin Forms in Atherosclerosis
por: Jang, Young-Saeng, et al.
Publicado: (2014) -
Plasma IL-5 concentration and subclinical carotid atherosclerosis
por: Silveira, Angela, et al.
Publicado: (2015)